BioNTech (BNTX) News Today $102.14 -4.26 (-4.00%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period BioNTech (NASDAQ:BNTX) Trading Down 2.2% - Here's What HappenedBioNTech (NASDAQ:BNTX) Stock Price Down 2.2% - What's Next?November 20 at 3:17 PM | marketbeat.comBioNTech SE: Strong Oncology Pipeline and Financial Position Offset Vaccine Business UncertaintyNovember 20 at 8:47 AM | markets.businessinsider.comBioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It.November 20 at 8:47 AM | yahoo.comPositive Report for BioNTech SE (BNTX) from Berenberg BankNovember 20 at 3:45 AM | markets.businessinsider.comEvercore ISI Group Upgrades BioNTech SE - Depositary Receipt () (BNTX)November 20 at 3:45 AM | msn.comBioNTech started at buy, Moderna at hold by BerenbergNovember 20 at 3:45 AM | seekingalpha.comIs BioNTech SE (BNTX) the Best German Stock to Buy Now?November 20 at 3:45 AM | msn.comBioNTech (NASDAQ:BNTX) Trading 4.9% Higher - Still a Buy?BioNTech (NASDAQ:BNTX) Trading Up 4.9% - Here's WhyNovember 19 at 3:29 PM | marketbeat.comBioNTech Stock Has Been Hit Hard Since RFK Jr.'s Nomination. Why This Analyst Upgraded It.November 19 at 11:57 AM | barrons.comBerenberg Bank Begins Coverage on BioNTech (NASDAQ:BNTX)Berenberg Bank started coverage on shares of BioNTech in a research report on Tuesday. They set a "buy" rating and a $130.00 price target for the company.November 19 at 7:33 AM | marketbeat.comBioNTech (NASDAQ:BNTX) Raised to "Outperform" at Evercore ISIEvercore ISI upgraded BioNTech from an "in-line" rating to an "outperform" rating and upped their price target for the stock from $110.00 to $125.00 in a research note on Tuesday.November 19 at 7:33 AM | marketbeat.comFY2024 EPS Estimates for BioNTech Cut by Leerink PartnrsNovember 19 at 2:29 AM | americanbankingnews.comBioNTech’s Strategic Acquisition of Biotheus Bolsters Oncology Portfolio and Justifies Buy RatingNovember 18 at 3:50 PM | markets.businessinsider.comGoldman Sachs Reaffirms Their Buy Rating on BioNTech SE (BNTX)November 18 at 8:32 AM | markets.businessinsider.comBioNTech's (BNTX) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $150.00 target price on shares of BioNTech in a research note on Monday.November 18 at 8:11 AM | marketbeat.comFY2024 EPS Estimates for BioNTech Decreased by AnalystBioNTech SE (NASDAQ:BNTX - Free Report) - Investment analysts at Leerink Partnrs reduced their FY2024 earnings per share (EPS) estimates for shares of BioNTech in a note issued to investors on Wednesday, November 13th. Leerink Partnrs analyst D. Graybosch now expects that the company will earn ($November 18 at 2:30 AM | marketbeat.comStrategic Acquisition and Oncology Focus Justify BioNTech’s Buy RatingNovember 16, 2024 | markets.businessinsider.comBioNTech SE (NASDAQ:BNTX) Short Interest UpdateBioNTech SE (NASDAQ:BNTX - Get Free Report) was the target of a large decline in short interest in October. As of October 31st, there was short interest totalling 2,020,000 shares, a decline of 16.2% from the October 15th total of 2,410,000 shares. Based on an average daily volume of 997,700 shares, the days-to-cover ratio is presently 2.0 days.November 15, 2024 | marketbeat.comBioNTech SE’s Strategic Growth in Oncology and mRNANovember 15, 2024 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX) and Idexx Laboratories (IDXX)November 15, 2024 | markets.businessinsider.comBioNTech's Options: A Look at What the Big Money is ThinkingNovember 15, 2024 | benzinga.comBioNTech (NASDAQ:BNTX) Shares Gap Down - Here's What HappenedBioNTech (NASDAQ:BNTX) Shares Gap Down - Time to Sell?November 15, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Given Buy Rating at Canaccord Genuity GroupCanaccord Genuity Group restated a "buy" rating and set a $171.00 price target on shares of BioNTech in a research report on Thursday.November 14, 2024 | marketbeat.comBioNTech To Buy Biotheus In Upfront Payment Of $800 MlnNovember 14, 2024 | finanznachrichten.deBioNTech Acquires Biotheus to Enhance Cancer TherapiesNovember 14, 2024 | markets.businessinsider.comBioNTech to buy bispecific antibody developer Biotheus for up to $950MNovember 14, 2024 | msn.comBioNTech to acquire Biotheus for upfront consideration of $800MNovember 14, 2024 | markets.businessinsider.comBioNTech to Acquire Biotheus for $800 Million to Expand Oncology PortfolioNovember 14, 2024 | finance.yahoo.comBioNTech buys China's Biotheus to support oncology strategyNovember 13, 2024 | reuters.comBioNTech to Acquire Biotheus to Boost Oncology StrategyNovember 13, 2024 | globenewswire.comDeutsche Bank Reaffirms Their Buy Rating on BioNTech SE (BNTX)November 12, 2024 | markets.businessinsider.comBaillie Gifford & Co. Acquires 31,773 Shares of BioNTech SE (NASDAQ:BNTX)Baillie Gifford & Co. increased its holdings in BioNTech SE (NASDAQ:BNTX - Free Report) by 0.4% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 8,308,071 shares of the company's stock after buying an additional 31,773 shares during the quarterNovember 12, 2024 | marketbeat.comBioNTech SE (BNTX) Gets a Buy from Morgan StanleyNovember 12, 2024 | markets.businessinsider.comUS Bancorp DE Trims Holdings in BioNTech SE (NASDAQ:BNTX)US Bancorp DE reduced its holdings in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 81.8% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 4,678 shares of the company's stock after selling 21,012 shares during the period. US Bancorp DE's holdings iNovember 11, 2024 | marketbeat.comBioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer PotentialNovember 9, 2024 | benzinga.comBioNTech upgraded to Buy from Neutral at Goldman SachsNovember 9, 2024 | markets.businessinsider.comWhat Analysts Are Saying About BioNTech StockNovember 9, 2024 | benzinga.comGoldman Sachs Upgrades BioNTech SE - Depositary Receipt () (BNTX)November 9, 2024 | msn.comThe Goldman Sachs Group Upgrades BioNTech (NASDAQ:BNTX) to BuyThe Goldman Sachs Group upgraded shares of BioNTech from a "neutral" rating to a "buy" rating and upped their target price for the stock from $90.00 to $137.00 in a research report on Friday.November 8, 2024 | marketbeat.comBioNTech SE’s Strategic Shift to Immuno-Oncology with BNT327: A Promising Investment Opportunity Amidst Stable COVID-19 ForecastsNovember 8, 2024 | markets.businessinsider.comFY2024 EPS Estimates for BioNTech Cut by HC WainwrightBioNTech SE (NASDAQ:BNTX - Free Report) - Equities research analysts at HC Wainwright cut their FY2024 earnings per share estimates for BioNTech in a research note issued on Tuesday, November 5th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings per share of ($5.November 7, 2024 | marketbeat.comRobeco Institutional Asset Management B.V. Cuts Stake in BioNTech SE (NASDAQ:BNTX)Robeco Institutional Asset Management B.V. trimmed its stake in BioNTech SE (NASDAQ:BNTX - Free Report) by 17.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 115,052 shares of the company's stock after selling 23,582 shares during the quaNovember 7, 2024 | marketbeat.comVan ECK Associates Corp Reduces Stock Position in BioNTech SE (NASDAQ:BNTX)Van ECK Associates Corp cut its stake in BioNTech SE (NASDAQ:BNTX - Free Report) by 21.0% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 94,685 shares of the company's stock after selling 25,216 shares during the quarter. VNovember 7, 2024 | marketbeat.comBioNTech’s Strong Oncology Pipeline and COVID-19 Vaccine Performance Earns Buy RatingNovember 6, 2024 | markets.businessinsider.comBioNTech Q3 Earnings Review: Good Quarter, Strong Promise -- But Still A HoldNovember 6, 2024 | seekingalpha.comResults: BioNTech SE Confounded Analyst Expectations With A Surprise ProfitNovember 6, 2024 | finance.yahoo.comBioNTech SE (NASDAQ:BNTX) Q3 2024 Earnings Call TranscriptNovember 5, 2024 | msn.comEvercore ISI Remains a Hold on BioNTech SE (BNTX)November 5, 2024 | markets.businessinsider.comDeutsche Bank Sticks to Their Buy Rating for BioNTech SE (BNTX)November 5, 2024 | markets.businessinsider.comTD Cowen Has Lowered Expectations for BioNTech (NASDAQ:BNTX) Stock PriceTD Cowen cut their price target on shares of BioNTech from $132.00 to $122.00 and set a "hold" rating for the company in a report on Tuesday.November 5, 2024 | marketbeat.com Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin BNTX Media Mentions By Week BNTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼0.310.45▲Average Medical News Sentiment BNTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼3511▲BNTX Articles Average Week Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News Today Takeda Pharmaceutical News Today Teva Pharmaceutical Industries News Today BeiGene News Today Viatris News Today Summit Therapeutics News Today Moderna News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Vaxcyte News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNTX Stock Alerts